版本:
中国

BRIEF-Eiger Biopharmaceuticals Q4 loss per share $1.53

March 23 Eiger Biopharmaceuticals Inc:

* Eiger biopharmaceuticals reports fourth quarter and full year 2016 financial results

* Q4 loss per share $1.53

* Q4 earnings per share view $-1.36 -- Thomson Reuters I/B/E/S

* Eiger Biopharmaceuticals Inc- as of Dec 31, 2016, eiger had cash, cash equivalents and short term marketable securities of $59.9 million, compared to $4.8 million at December 31, 2015 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐